Silver nanoparticles in mouthwashes against infection caused by SARS-CoV-2: a scoping review

Autores/as

  • Kelly Fernanda Molena Pós Graduanda do Programa de Odontopediatria, Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil https://orcid.org/0000-0002-7290-8451
  • Camila Raíssa Oliveira Gontijo Martins Pós Graduanda do Programa de Odontopediatria, Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil https://orcid.org/0000-0001-7006-469X
  • Carolina Alves Freiria de Oliveira Pós Graduanda do Programa de Reabilitação Oral Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil. https://orcid.org/0000-0001-7317-3429
  • Murilo Fernando Neuppmann Feres Departamento de Clínica Infantil, Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil https://orcid.org/0000-0002-7185-544X
  • Alexandra Mussolino de Queiroz Departamento de Clínica Infantil, Faculdade de Odontologia de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil https://orcid.org/0000-0003-2900-5000

DOI:

https://doi.org/10.4322/bds.2023.e3721

Resumen

The Silver nanoparticle (AgNPs) have received attention for their antiviral potential against SARS-CoV-2. The objective is to conduct a scope review and map the scientific evidence on the use of AgNPs in mouthwashes as an adjunct in decreasing the viral load in the oral cavity of patients with SARS-CoV-2. A search was performed in the PubMed, Medline, Scielo databases, and a manual search in the reference lists, following the standards of the Joanna Briggs Institute for Scoping Review without restriction of year, language or sample size. Thus, 14 articles were included, where they researched the use of AgNPs with antiviral effect against SARS-CoV-2, mouthwashes for SARS-CoV-2 and AgNPs as mouthwashes. We can suggest that AgNPs are likely antiviral therapies for SARS-CoV-2 and its use in mouthwashes associated with other therapies are promising strands for decreasing viral load and infection by the virus.

KEYWORDS

Nanoparticles; Silver; Mouthwashes; COVID-19; SARS-CoV-2.

Descargas

Los datos de descargas todavía no están disponibles.

Descargas

Publicado

2023-06-21

Cómo citar

1.
Molena KF, Martins CROG, Oliveira CAF de, Feres MFN, Queiroz AM de. Silver nanoparticles in mouthwashes against infection caused by SARS-CoV-2: a scoping review. BDS [Internet]. 21 de junio de 2023 [citado 8 de septiembre de 2025];26(2). Disponible en: https://ojs.ict.unesp.br/index.php/cob/article/view/3721

Número

Vol. 26 Núm. 2 (2023): Apr - Jun / 2023 - Published Mar 2023

Sección

Literature Review

Licencia

Brazilian Dental Science uses the Creative Commons (CC-BY 4.0) license, thus preserving the integrity of articles in an open access environment. The journal allows the author to retain publishing rights without restrictions.

=================

COPYRIGHT TRANSFER AND RESPONSIBILITY STATEMENT
 (PDF)

For all articles published in the BDS journal, copyright is retained by the authors. Articles are licensed under an open-access Creative Commons CC BY 4.0 license, meaning that anyone may download and read the paper for free. In addition, the article may be reused and quoted, provided that the original published version is cited. These conditions allow for maximum use and exposure of the work while ensuring that the authors receive proper credit. All metadata associated with published articles is released under the Creative Commons CC0 Universal Public Domain Dedication.

Before the submission, authors must obtain permission to reproduce any published material (figures, schemes, tables, or any extract of a text) that does not fall into the public domain or for which they do not hold the copyright. Permission should be requested by the authors from the copyright holder (usually the Publisher, please refer to the imprint of the individual publications to identify the copyright holder).

The authors hereby attest that the study is original and does not present manipulated data, fraud, or plagiarism. All names listed made a significant scientific contribution to the study, are aware of the presented data, and agree with the final version of the manuscript. They assume complete responsibility for the ethical aspects of the study.

This text must be printed and signed by all authors. The scanned version should be submitted as supplemental file during the submission process.